These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 7577964)
1. Reduced albumin binding promotes the stability and activity of topotecan in human blood. Mi Z; Malak H; Burke TG Biochemistry; 1995 Oct; 34(42):13722-8. PubMed ID: 7577964 [TBL] [Abstract][Full Text] [Related]
2. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. Burke TG; Mi Z J Med Chem; 1994 Jan; 37(1):40-6. PubMed ID: 8289200 [TBL] [Abstract][Full Text] [Related]
3. Differential interactions of camptothecin lactone and carboxylate forms with human blood components. Mi Z; Burke TG Biochemistry; 1994 Aug; 33(34):10325-36. PubMed ID: 8068669 [TBL] [Abstract][Full Text] [Related]
4. Stabilization of the Karenitecin® lactone by alpha-1 acid glycoprotein. Yao S; Petluru P; Parker A; Ding D; Chen X; Huang Q; Kochat H; Hausheer F Cancer Chemother Pharmacol; 2015 Apr; 75(4):719-28. PubMed ID: 25634596 [TBL] [Abstract][Full Text] [Related]
5. Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin. Prijovich ZM; Leu YL; Roffler SR Cancer Chemother Pharmacol; 2007 Jun; 60(1):7-17. PubMed ID: 16983566 [TBL] [Abstract][Full Text] [Related]
6. Stability of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in the presence of human serum albumin. Prijovich ZM; Leu YL; Roffler SR Biochem Pharmacol; 2003 Oct; 66(7):1181-7. PubMed ID: 14505797 [TBL] [Abstract][Full Text] [Related]
7. Kinetic and thermodynamic studies of 9-aminocamptothecin hydrolysis at physiological pH in the presence of human serum albumin. Patel D; Rahman S; Savva M Eur J Pharm Sci; 2013 Aug; 49(5):858-63. PubMed ID: 23791639 [TBL] [Abstract][Full Text] [Related]
8. The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity. Bom D; Curran DP; Kruszewski S; Zimmer SG; Thompson Strode J; Kohlhagen G; Du W; Chavan AJ; Fraley KA; Bingcang AL; Latus LJ; Pommier Y; Burke TG J Med Chem; 2000 Oct; 43(21):3970-80. PubMed ID: 11052802 [TBL] [Abstract][Full Text] [Related]
9. Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks. Bailly C; Lansiaux A; Dassonneville L; Demarquay D; Coulomb H; Huchet M; Lavergne O; Bigg DC Biochemistry; 1999 Nov; 38(47):15556-63. PubMed ID: 10569939 [TBL] [Abstract][Full Text] [Related]
10. Properties of Ultraviolet Exposed Camptothecin Studied by Using Optical Spectroscopy Methods. Ziomkowska B; Wybranowski T; Cyrankiewicz M; Kruszewski S Comb Chem High Throughput Screen; 2016; 19(4):319-24. PubMed ID: 26953237 [TBL] [Abstract][Full Text] [Related]
12. Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine. Burke TG; Gao X J Pharm Sci; 1994 Jul; 83(7):967-9. PubMed ID: 7965676 [TBL] [Abstract][Full Text] [Related]
13. Simple and versatile high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of camptothecin anticancer drugs. Warner DL; Burke TG J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):161-71. PubMed ID: 9140770 [TBL] [Abstract][Full Text] [Related]
14. Determination of hydroxycamptothecin affinities to albumin and membranes by steady-state fluorescence anisotropy measurements. Ziomkowska B; Cyrankiewicz M; Kruszewski S Comb Chem High Throughput Screen; 2007 Jul; 10(6):486-92. PubMed ID: 17896945 [TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma. Rosing H; Doyle E; Davies BE; Beijnen JH J Chromatogr B Biomed Appl; 1995 Jun; 668(1):107-15. PubMed ID: 7550966 [TBL] [Abstract][Full Text] [Related]
16. Hydroxycamptothecin deactivation rates and binding to model membranes and HSA determined by fluorescence spectra analysis. Ziomkowska B; Cyrankiewicz M; Kruszewski S Comb Chem High Throughput Screen; 2007 Jul; 10(6):459-65. PubMed ID: 17896941 [TBL] [Abstract][Full Text] [Related]
17. Marked interspecies variations concerning the interactions of camptothecin with serum albumins: a frequency-domain fluorescence spectroscopic study. Mi Z; Burke TG Biochemistry; 1994 Oct; 33(42):12540-5. PubMed ID: 7918477 [TBL] [Abstract][Full Text] [Related]
18. Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Blaney SM; Cole DE; Balis FM; Godwin K; Poplack DG Cancer Res; 1993 Feb; 53(4):725-7. PubMed ID: 8428353 [TBL] [Abstract][Full Text] [Related]
19. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs. Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837 [TBL] [Abstract][Full Text] [Related]
20. The comparison of biophysical properties of DB-67 and its ester DB-67-4ABTFA determined by fluorescence spectroscopy methods. Kruszewski S; Ziomkowska B; Cyrankiewicz M; Wybranowski T Biosystems; 2008 Dec; 94(3):270-5. PubMed ID: 18718502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]